Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul, Korea.
Research Institute of Advanced Materials (RIAM), Seoul National University, Seoul, Korea.
Ann Lab Med. 2022 Nov 1;42(6):638-649. doi: 10.3343/alm.2022.42.6.638.
Adoptive cell therapy using umbilical cord blood (UCB)-derived allogeneic natural killer (NK) cells has shown encouraging results. However, because of the insufficient availability of NK cells and limited UCB volume, more effective culture methods are required. NK cell expansion and functionality are largely affected by the culture medium. While human serum is a major affecting component in culture media, the way it regulates NK cell functionality remains elusive. We elucidated the effects of different culture media and human serum supplementation on UCB NK cell expansion and functionality.
UCB NK cells were cultured under stimulation with K562-OX40L-mbIL-18/21 feeder cells and IL-2 and IL-15 in serum-containing and serum-free culture media. The effects of the culture media and human serum supplementation on NK cell expansion and cytotoxicity were evaluated by analyzing the expansion rate, activating and inhibitory receptor levels, and the cytotoxicity of the UCB NK cells.
The optimal medium for NK cell expansion was Dulbecco's modified Eagle's medium/Ham's F12 with supplements and that for cytotoxicity was AIM V supplemented with Immune Cell Serum Replacement. Shifting media is an advantageous strategy for obtaining several highly functional UCB NK cells. Live cell imaging and killing time measurement revealed that human serum enhanced NK cell proliferation but delayed target recognition, resulting in reduced cytotoxicity.
Culture medium supplementation with human serum strongly affects UCB NK cell expansion and functionality. Thus, culture media should be carefully selected to ensure both NK cell quantity and quality for adoptive cell therapy.
使用脐带血(UCB)来源的同种异体自然杀伤(NK)细胞的过继细胞疗法已显示出可喜的结果。然而,由于 NK 细胞的供应不足和 UCB 体积有限,需要更有效的培养方法。NK 细胞的扩增和功能在很大程度上受到培养基的影响。虽然人血清是培养基中的主要影响成分,但它调节 NK 细胞功能的方式仍不清楚。我们阐明了不同培养基和人血清补充对 UCB NK 细胞扩增和功能的影响。
在 K562-OX40L-mbIL-18/21 饲养细胞和 IL-2 和 IL-15 的刺激下,UCB NK 细胞在含血清和无血清培养基中培养。通过分析 NK 细胞的扩增率、激活和抑制受体水平以及 UCB NK 细胞的细胞毒性,评估培养基和人血清补充对 NK 细胞扩增和细胞毒性的影响。
NK 细胞扩增的最佳培养基是含有补充剂的 Dulbecco 改良 Eagle 培养基/Ham's F12,细胞毒性的最佳培养基是补充 Immune Cell Serum Replacement 的 AIM V。更换培养基是获得几种高功能 UCB NK 细胞的有利策略。活细胞成像和杀伤时间测量表明,人血清增强了 NK 细胞的增殖,但延迟了靶标识别,导致细胞毒性降低。
人血清对 UCB NK 细胞的扩增和功能有很强的影响。因此,应仔细选择培养基,以确保过继细胞疗法中 NK 细胞的数量和质量。